Expert panel makes recommendation to government on drugs and driving

An independent panel of experts, including an academic from Queen Mary, University of London, which was tasked by the government to make recommendations regarding drugs and driving, has published its report.

Atholl Johnston, Professor of at Queen Mary, was one of the panel of experts asked by the Department for Transport in April 2012 to make recommendations about which drugs listed in the Misuse of Drugs Act (1971) should be included in regulations for the new drug- offence. They were also asked to consider what thresholds for these drugs should be set in regulations to improve .

Professor Johnston regularly gives evidence to the courts in relation to drugs, alcohol, and driving and was appointed to the panel for his expertise in the assessment of drug action in humans and the measurement of drugs in .

The government is introducing a new offence of driving or being in charge of a with a specified controlled drug in the body. The new offence is included in the Crime and Courts Bill, currently before Parliament.

The report from the independent panel, which was led by Dr Kim Wolff, Reader in Addiction Science at King's College London, will now be considered by the government as it develops specific proposals regarding the drugs to be specified in regulations for the new offence. These proposals will be subject to a public consultation.

Professor Atholl Johnston said: "Driving while impaired by drugs is dangerous. The recommendations of the panel, supported by scientific evidence, set out limits for the concentrations of drugs in blood that would bring the of the offence of drug-driving in-line with that of drink-driving.

"The panel also recognised that the impairment in driving ability caused by the combination of drugs and alcohol is more serious than either alone and proposes lower limits for drugs and alcohol when both are present."

Dr Kim Woolff said: "The panel is grateful to have been given the opportunity to collate the drug-driving literature in such a comprehensive way and is satisfied that the strength of the evidence is extremely compelling.

"The panel recognises the complexity of the report findings and the potential wide-ranging impact of the recommendations on healthcare professionals, the police authorities and the general public, and urges the to take into consideration the robust evidence we have gathered in relation to the new driving legislation."

"Driving under the Influence of Drugs – an Independent Report by the Expert Panel" is published online here along with a written ministerial statement from Stephen Hammond MP, Parliamentary Under Secretary of State for Transport.

add to favorites email to friend print save as pdf

Related Stories

Indian expert panel to probe drugs regulator

May 11, 2012

India's Health Ministry said Friday it had set up an expert panel to review the operations of its drug regulatory agency, accused of colluding with pharmaceutical firms to approve drugs without trials.

India probes charges of violations by drugs regulator

May 10, 2012

India's Health Ministry said Thursday it was examining charges that the government's top drug regulatory agency had colluded with pharmaceutical firms to approve drugs without proper clinical trials.

Study calls for drug-driving crackdown

Nov 26, 2012

(Medical Xpress)—Drug-impaired driving is a growing problem in Canada that remains dramatically under-enforced and, if enforced at all, is time-consuming, unwieldy and fails to identify the vast majority of drug-impaired ...

FDA panel supports continued testing of pain drugs

Mar 12, 2012

(AP) -- A panel of arthritis experts has recommended that the federal government allow continued testing of an experimental class of pain drugs for arthritis, despite links to bone decay and joint failure

Recommended for you

Merck completes sale of consumer unit to Bayer

3 hours ago

Drugmaker Merck said Wednesday that it completed the sale of its consumer care business, which makes products including Claritin allergy medication and Coppertone sun-care line, to German health care company Bayer for $14.2 ...

Viagra ads target women for first time

Sep 30, 2014

The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial in America that targets the less-obvious sufferers of the sexual condition: women.

User comments